Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ImmunityBio, Inc. | CEO & President, Director | Restricted Stock Units | 457K | $1.85M | $4.04 | Feb 22, 2024 | Direct |
ImmunityBio, Inc. | CEO & President, Director | Common Stock | 243K | $982K | $4.04 | Feb 5, 2024 | Direct |
ImmunityBio, Inc. | CEO & President, Director | Stock Option (right to buy) | 1.59M | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IBRX | ImmunityBio, Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Feb 5, 2024 | 3 | -$174K | 4 | Feb 6, 2024 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Dec 31, 2023 | 3 | -$85.8K | 4 | Jan 3, 2024 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Feb 5, 2023 | 3 | -$183K | 4 | Feb 7, 2023 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Dec 31, 2022 | 3 | -$21.7K | 4 | Jan 4, 2023 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Mar 23, 2022 | 2 | $0 | 4 | Mar 25, 2022 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Feb 5, 2022 | 3 | -$159K | 4 | Feb 8, 2022 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Oct 8, 2021 | 2 | $17K | 4 | Oct 8, 2021 | CEO & President, Director |
IBRX | ImmunityBio, Inc. | Sep 9, 2021 | 3 | -$42.5K | 4 | Sep 13, 2021 | Chief Executive Officer, Director |